Key points are not available for this paper at this time.
Personalized medicine, driven by advancements in pharmacology, is revolutionizing healthcare by tailoring medical treatments to the unique characteristics of individual patients. This paradigm shift from a generalized approach to a patient-centric model holds great promise in improving treatment outcomes, minimizing adverse reactions, and optimizing the cost-effectiveness of drug discovery and development. This article explores the concept of personalized medicine and highlights the pivotal role played by advancements in pharmacology in enabling tailored treatment approaches. We discuss key components of personalized medicine, including genomics, pharmacogenomics, biomarker discovery, targeted therapies, and the integration of technology and data analytics. Furthermore, we examine the potential impact of personalized medicine on various medical specialties and healthcare sectors, such as oncology, cardiology, and mental health. The article concludes by emphasizing the need for continued research, collaboration, and investment in pharmacology to unlock the full potential of personalized medicine in improving patient care. Keywords: Personalized medicine, Precision medicine, Pharmacology, Genomics, Pharmacogenomics
B. Kishore Babu (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: